Publication

An Unsuccessful Randomized Trial of Percutaneous vs Endoscopic Drainage of Suspected Malignant Hilar Obstruction

Downloadable Content

Persistent URL
Last modified
  • 08/27/2025
Type of Material
Authors
    Field Willingham, Emory UniversityJoseph B Elmunzer, Medical University of South CarolinaZachary L Smith, Case Western Reserve UniversityPaul Tarnasky, Methodist Dallas Medical CenterAndrew Y Wang, University of VirginiaPatrick Yachimski, Vanderbilt UniversityFilip Banovac, Vanderbilt UniversityJonathan M Buscaglia, SUNY Stony BrookJames Buxbaum, University of Southern CaliforniaAmitabh Chak, Case Western Reserve UniversityBradford Chong, University of Southern CaliforniaGregory A Cote, Medical University of South CarolinaPeter V Draganov, University of FloridaKulwinder Dua, Medical College of WisconsinValerie Durkalski, Medical University of South CarolinaBrian S Geller, University of FloridaLaith H Jamil, Cedars Sinai Medical CenterRajesh N Keswani, Northwestern UniversityMouen A Khashab, Johns Hopkins Medical InstitutionsRyan Law, University of MichiganSimon K Lo, Cedars Sinai Med CtrSean McCarthy, Ohio State UniversityBayne J Selby, Medical University of South CarolinaVikesh K Singh, Johns Hopkins Medical InstitutionsJason R Taylor, St Louis UniversityRebecca L Spitzer, Medical University of South CarolinaLydia D Foster, Medical University of South Carolina
Language
  • English
Date
  • 2021-05-08
Publisher
  • ELSEVIER SCIENCE INC
Publication Version
Copyright Statement
  • © 2021 by the AGA Institute
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 19
Issue
  • 6
Start Page
  • 1282
End Page
  • 1284
Supplemental Material (URL)
Abstract
  • Percutaneous transhepatic biliary drainage (PTBD) and endoscopic retrograde cholangiopancreatography (ERCP) are widely accepted but competing approaches for the management of malignant obstruction at the hilum of the liver. ERCP is favored in the United States on the basis of high success rates for non-hilar indications, the perceived safety and superior tissue sampling capability of ERCP relative to PTBD, and the avoidance of external drains that are undesirable to patients. A recent randomized controlled trial (RCT) comparing the 2 modalities in patients with resectable hilar cholangiocarcinoma was terminated prematurely because of higher mortality in the PTBD group.1 In contrast, most observational data suggest that PTBD is superior for achieving complete drainage.2-6 Because the preferred procedure remains uncertain, we aimed to compare PTBD and ERCP as the primary intervention in patients with cholestasis due to malignant hilar obstruction (MHO).
Author Notes
  • B. Joseph Elmunzer, MD, Division of Gastroenterology and Hepatology, Medical University of South Carolina, MSC 702, 114 Doughty Street, Suite 249, Charleston, South Carolina 29425. fax: (843) 876-4261. Email: elmunzer@musc.edu
Keywords

Tools

Relations

In Collection:

Items